Literature DB >> 14985260

Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome.

K Stiasny-Kolster1, W Magerl, W H Oertel, J C Möller, R-D Treede.   

Abstract

Pain sensitivity was assessed in 11 patients (age 60 +/- 10 years) with 'primary' restless leg syndrome (RLS) (disease duration 18 +/- 15 years) and 11 age- and gender-matched healthy control subjects. Stimulus-response functions for pricking pain were obtained with seven calibrated punctate mechanical stimulators activating Adelta-high threshold mechano-nociceptors. Stimuli at the foot were significantly more painful than at the hand in both patients and healthy control subjects both in the morning and evening. Generally, pin-prick pain ratings in RLS patients were significantly elevated, by a factor of 5.3 in the upper limb and by a factor of 6.4 in the lower limb indicating a significant generalized static hyperalgesia more pronounced in the lower limb. In contrast, pain to light touch (allodynia = dynamic mechanical hyperalgesia) as tested by a battery of three gentle tactile stimuli was never reported. Acute single-dose dopaminergic treatment with 100 mg levodopa + 25 mg benserazide, 90 min prior to the evening measurements, largely resolved patients' RLS symptoms, but had no effect on pin-prick pain. Static hyperalgesia to pin-prick, however, was significantly reversed (median reduction -74%) by long-term individually tailored dopaminergic treatment. Our study shows that patients with RLS exhibit a profound static mechanical hyperalgesia to pin-prick stimuli, but no dynamic mechanical hyperalgesia (allodynia). This type of hyperalgesia is probably mediated by central sensitization to Adelta-fibre high-threshold mechanoreceptor input, a hallmark sign of the hyperalgesia type of neuropathic pain. The reduction of hyperalgesia in RLS patients by long-term dopaminergic treatment suggests that the pathophysiology of RLS includes disturbed supraspinal pain modulation involving the basal ganglia and/or descending dopaminergic pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985260     DOI: 10.1093/brain/awh079

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  35 in total

Review 1.  [Nociceptive system : Nociceptors, fiber types, spinal pathways, and projection areas].

Authors:  U Baumgärtner
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

Review 2.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

Review 3.  Quantitative sensory testing of neuropathic pain patients: potential mechanistic and therapeutic implications.

Authors:  Doreen B Pfau; Christian Geber; Frank Birklein; Rolf-Detlef Treede
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 4.  [Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].

Authors:  S Happe; W Paulus
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

5.  Risk factors predicting the development of widespread pain from chronic back or neck pain.

Authors:  Lindsay L Kindler; Kim D Jones; Nancy Perrin; Robert M Bennett
Journal:  J Pain       Date:  2010-05-21       Impact factor: 5.820

6.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

7.  Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Authors:  Robert R Edwards; Phillip J Quartana; Richard P Allen; Seth Greenbaum; Christopher J Earley; Michael T Smith
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

8.  Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-07-31       Impact factor: 3.332

9.  The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample.

Authors:  Randy Neblett; Howard Cohen; YunHee Choi; Meredith M Hartzell; Mark Williams; Tom G Mayer; Robert J Gatchel
Journal:  J Pain       Date:  2013-03-13       Impact factor: 5.820

10.  Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

Authors:  Quentin Barraud; Ibrahim Obeid; Incarnation Aubert; Gregory Barrière; Hugues Contamin; Steve McGuire; Paula Ravenscroft; Gregory Porras; François Tison; Erwan Bezard; Imad Ghorayeb
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.